72 related articles for article (PubMed ID: 16205101)
1. [EGF receptor blockade with monoclonal antibodis and so-called "small molecules"].
Ciardiello F; Ma B
Onkologie; 2005 Oct; 28 Suppl 4():18-24. PubMed ID: 16205101
[No Abstract] [Full Text] [Related]
2. [Basic principles of signal transduction].
Yarden Y
Onkologie; 2005 Oct; 28 Suppl 4():14-7. PubMed ID: 16205100
[No Abstract] [Full Text] [Related]
3. [An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors].
Lang A; Graeven U
Zentralbl Chir; 2009 Jun; 134(3):189-92. PubMed ID: 19544236
[No Abstract] [Full Text] [Related]
4. [Clinical development of targeted moledular cancer drugs].
Zwierzina H; Borner M
Onkologie; 2005 Oct; 28 Suppl 4():35-9. PubMed ID: 16205104
[No Abstract] [Full Text] [Related]
5. [Inhibition of angiogenesis by proteins, peptides and "small molecules"].
Jayson G; Armand JP; Berdel WE
Onkologie; 2005 Oct; 28 Suppl 4():29-34. PubMed ID: 16205103
[No Abstract] [Full Text] [Related]
6. Clinical trials referral resource. Epidermal growth factor receptor inhibitors in clinical trials.
Dancey JE; Schoenfeldt M
Oncology (Williston Park); 2001 Jun; 15(6):748-50, 756-8. PubMed ID: 11430207
[No Abstract] [Full Text] [Related]
7. EGFR targeting therapies: monoclonal antibodies versus tyrosine kinase inhibitors. Similarities and differences.
Dassonville O; Bozec A; Fischel JL; Milano G
Crit Rev Oncol Hematol; 2007 Apr; 62(1):53-61. PubMed ID: 17324578
[TBL] [Abstract][Full Text] [Related]
8. Rational bases for the development of EGFR inhibitors for cancer treatment.
Bianco R; Gelardi T; Damiano V; Ciardiello F; Tortora G
Int J Biochem Cell Biol; 2007; 39(7-8):1416-31. PubMed ID: 17596994
[TBL] [Abstract][Full Text] [Related]
9. [Cetuximab. A monoclonal antibody against the EGF receptor].
Wasielewski S
Med Monatsschr Pharm; 2004 Sep; 27(9):292-4. PubMed ID: 15490614
[No Abstract] [Full Text] [Related]
10. Targeting epidermal growth factor receptor signaling: early results and future trends in oncology.
Lage A; Crombet T; González G
Ann Med; 2003; 35(5):327-36. PubMed ID: 12952019
[TBL] [Abstract][Full Text] [Related]
11. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic growth factor receptors: implications for signal transduction therapy.
Mosesson Y; Yarden Y
Semin Cancer Biol; 2004 Aug; 14(4):262-70. PubMed ID: 15219619
[TBL] [Abstract][Full Text] [Related]
13. Anti-EGFR therapy update: clinical experience and adverse event insights.
Harari PM
Oncology (Williston Park); 2006 Apr; 20(5 Suppl 2):3-4. PubMed ID: 16736977
[No Abstract] [Full Text] [Related]
14. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor: a promising target in solid tumours.
Laskin JJ; Sandler AB
Cancer Treat Rev; 2004 Feb; 30(1):1-17. PubMed ID: 14766123
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Motoyama AB; Hynes NE; Lane HA
Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor (EGFR) inhibitors in gastrointestinal cancer.
Macarulla T; Casado E; Ramos FJ; Valverde C; Tabernero J
Onkologie; 2006 Mar; 29(3):99-105. PubMed ID: 16514271
[TBL] [Abstract][Full Text] [Related]
18. Combined targeted therapies in non-small cell lung cancer: a winner strategy?
Cascone T; Gridelli C; Ciardiello F
Curr Opin Oncol; 2007 Mar; 19(2):98-102. PubMed ID: 17272980
[TBL] [Abstract][Full Text] [Related]
19. Blepharitis induced by epidermal growth factor receptor-targeting therapy.
Ulusakarya A; Gumus Y; Delmas-Marsalet B; Machover D
Am J Clin Oncol; 2006 Oct; 29(5):531. PubMed ID: 17023793
[No Abstract] [Full Text] [Related]
20. [EGFR-targeted therapies: what's new?].
Vignot S; Besse B; Soria JC; Milano G; Spano JP
Bull Cancer; 2006 Jan; 93(1):13-8. PubMed ID: 16455501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]